Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for NSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.0562M
March 31, 2026 0.0898M
December 31, 2025 0.0003M
September 30, 2025 0.0006M
June 30, 2025 0.0011M
March 31, 2025 0.0034M
December 31, 2024 0.0061M
September 30, 2024 0.0453M
June 30, 2024 0.0079M
March 31, 2024 0.0052M
December 31, 2023 0.0531M
September 30, 2023 0.007M
June 30, 2023 0.0343M
March 31, 2023 0.0406M
December 31, 2022 0.0063M
September 30, 2022 0.0169M
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
Date Value
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Brainstorm Cell Therapeutics, Inc. 0.022M
Summit Therapeutics, Inc. 691.00M
Kezar Life Sciences, Inc. 66.23M
Protara Therapeutics, Inc. 142.49M
Clene, Inc. 9.671M